Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuro-immunology
When do you offer high-dose vitamin D for patients with multiple sclerosis with normal serum levels?
In light of publication from
Thouvenot et al in JAMA
Related Questions
How frequently do you recommend ordering labs to monitor for side effects of disease-modifying therapies for multiple sclerosis?
How would you manage a patient with LGI-1 encephalitis with faciobracial dystonic seizures who has not improved with 3 days of intravenous steroids?
Can you use a JAK inhibitor and Mavenclad in a patient with both multiple sclerosis and rheumatoid arthritis?
What is your workup and treatment approach for cranial neuropathies in patients with lupus?
What baseline visual testing, if any, do you recommend at diagnosis for patients with multiple sclerosis who deny visual complaints?
What are your vaccine recommendations while patients are on biologics?
What is your initial treatment paradigm for someone with both CNS and peripheral neurologic Sjogren’s?
What is your approach to immune management in opsoclonus-myoclonus-ataxia syndrome?
How would you approach the decision to escalate DMT in a patient with relapsing multiple sclerosis who has two to three new T2 lesion but no clinical symptoms?
What is your disease modifying treatment of choice for a patient with relapsing remitting multiple sclerosis with treated, well controlled HIV?